{"id":234333,"date":"2026-06-20T23:54:26","date_gmt":"2026-06-20T23:54:26","guid":{"rendered":"https:\/\/dailytalks.org\/?p=234333"},"modified":"2026-06-20T23:54:26","modified_gmt":"2026-06-20T23:54:26","slug":"era-2026-hightide-therapeutics-presents-new-findings-supporting-htd1801s-renoprotective-potential-in-oral-presentation","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=234333","title":{"rendered":"ERA 2026: HighTide Therapeutics Presents New Findings Supporting HTD1801&#8217;s Renoprotective Potential in Oral Presentation"},"content":{"rendered":"<p>GLASGOW \/ HONG KONG &#8211; Jun 5, 2026 &#8211; (ACN Newswire) &#8211;\u00a0HighTide Therapeutics, Inc. (2511.HK), an innovative biopharmaceutical company specializing in the development of multifunctional, multi-targeted therapies for cardiovascular\u2013kidney\u2013metabolic (CKM) diseases, today presented new findings on the renoprotective effects of its lead candidate HTD1801 in an oral presentation at the 63rd European Renal Association (ERA) Congress in Glasgow&#8230;<br \/><a href=\"https:\/\/en.acnnewswire.com\/press-release\/english\/107567\/\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>GLASGOW \/ HONG KONG &#8211; Jun 5, 2026 &#8211; (ACN Newswire) &#8211;\u00a0HighTide Therapeutics, Inc. (2511.HK),<\/p>\n","protected":false},"author":1,"featured_media":234334,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[],"class_list":["post-234333","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-europe"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2026\/06\/234333-era-2026-hightide-therapeutics-presents-new-findings-supporting-htd1801s-renoprotective-po6a37283dc0fc3.jpg",220,56,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2026\/06\/234333-era-2026-hightide-therapeutics-presents-new-findings-supporting-htd1801s-renoprotective-po6a37283dc0fc3-150x56.jpg",150,56,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2026\/06\/234333-era-2026-hightide-therapeutics-presents-new-findings-supporting-htd1801s-renoprotective-po6a37283dc0fc3.jpg",220,56,false],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2026\/06\/234333-era-2026-hightide-therapeutics-presents-new-findings-supporting-htd1801s-renoprotective-po6a37283dc0fc3.jpg",220,56,false],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2026\/06\/234333-era-2026-hightide-therapeutics-presents-new-findings-supporting-htd1801s-renoprotective-po6a37283dc0fc3.jpg",220,56,false],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2026\/06\/234333-era-2026-hightide-therapeutics-presents-new-findings-supporting-htd1801s-renoprotective-po6a37283dc0fc3.jpg",220,56,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2026\/06\/234333-era-2026-hightide-therapeutics-presents-new-findings-supporting-htd1801s-renoprotective-po6a37283dc0fc3.jpg",220,56,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2026\/06\/234333-era-2026-hightide-therapeutics-presents-new-findings-supporting-htd1801s-renoprotective-po6a37283dc0fc3.jpg",220,56,false],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2026\/06\/234333-era-2026-hightide-therapeutics-presents-new-findings-supporting-htd1801s-renoprotective-po6a37283dc0fc3.jpg",220,56,false],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2026\/06\/234333-era-2026-hightide-therapeutics-presents-new-findings-supporting-htd1801s-renoprotective-po6a37283dc0fc3.jpg",220,56,false]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=16\" rel=\"category\">Europe<\/a>","tag_info":"Europe","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/234333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=234333"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/234333\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/234334"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=234333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=234333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=234333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}